EVGN
Price
$2.28
Change
-$0.00 (-0.00%)
Updated
Oct 31 closing price
12 days until earnings call
FATE
Price
$2.37
Change
-$0.00 (-0.00%)
Updated
Oct 31 closing price
121 days until earnings call
Ad is loading...

EVGN vs FATE

Header iconEVGN vs FATE Comparison
Open Charts EVGN vs FATEBanner chart's image
Evogene
Price$2.28
Change-$0.00 (-0.00%)
Volume$13.41M
CapitalizationN/A
Fate Therapeutics
Price$2.37
Change-$0.00 (-0.00%)
Volume$1.83M
CapitalizationN/A
View a ticker or compare two or three
EVGN vs FATE Comparison Chart
Loading...
EVGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
FATE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
EVGN vs. FATE commentary
Nov 02, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVGN is a Hold and FATE is a Hold.

COMPARISON
Comparison
Nov 02, 2024
Stock price -- (EVGN: $2.28 vs. FATE: $2.37)
Brand notoriety: EVGN and FATE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EVGN: 4230% vs. FATE: 152%
Market capitalization -- EVGN: $15.76M vs. FATE: $276.72M
EVGN [@Biotechnology] is valued at $15.76M. FATE’s [@Biotechnology] market capitalization is $276.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVGN’s FA Score shows that 0 FA rating(s) are green whileFATE’s FA Score has 1 green FA rating(s).

  • EVGN’s FA Score: 0 green, 5 red.
  • FATE’s FA Score: 1 green, 4 red.
According to our system of comparison, FATE is a better buy in the long-term than EVGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVGN’s TA Score shows that 6 TA indicator(s) are bullish while FATE’s TA Score has 4 bullish TA indicator(s).

  • EVGN’s TA Score: 6 bullish, 2 bearish.
  • FATE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, EVGN is a better buy in the short-term than FATE.

Price Growth

EVGN (@Biotechnology) experienced а -5.00% price change this week, while FATE (@Biotechnology) price change was -15.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

EVGN is expected to report earnings on Mar 06, 2025.

FATE is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FATE($277M) has a higher market cap than EVGN($12.7M). FATE YTD gains are higher at: -36.631 vs. EVGN (-72.857). EVGN has higher annual earnings (EBITDA): -18.81M vs. FATE (-176.34M). FATE has more cash in the bank: 305M vs. EVGN (20.9M). EVGN has less debt than FATE: EVGN (11.2M) vs FATE (101M). FATE has higher revenues than EVGN: FATE (12.3M) vs EVGN (9.45M).
EVGNFATEEVGN / FATE
Capitalization12.7M277M5%
EBITDA-18.81M-176.34M11%
Gain YTD-72.857-36.631199%
P/E Ratio0.30N/A-
Revenue9.45M12.3M77%
Total Cash20.9M305M7%
Total Debt11.2M101M11%
FUNDAMENTALS RATINGS
EVGN vs FATE: Fundamental Ratings
EVGN
FATE
OUTLOOK RATING
1..100
157
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
27
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9996
PRICE GROWTH RATING
1..100
9565
P/E GROWTH RATING
1..100
90100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FATE's Valuation (27) in the Biotechnology industry is in the same range as EVGN (55). This means that FATE’s stock grew similarly to EVGN’s over the last 12 months.

FATE's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as EVGN (100). This means that FATE’s stock grew similarly to EVGN’s over the last 12 months.

FATE's SMR Rating (96) in the Biotechnology industry is in the same range as EVGN (99). This means that FATE’s stock grew similarly to EVGN’s over the last 12 months.

FATE's Price Growth Rating (65) in the Biotechnology industry is in the same range as EVGN (95). This means that FATE’s stock grew similarly to EVGN’s over the last 12 months.

EVGN's P/E Growth Rating (90) in the Biotechnology industry is in the same range as FATE (100). This means that EVGN’s stock grew similarly to FATE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EVGNFATE
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
79%
Bullish Trend 15 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
EVGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
FATE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL225.91-4.19
-1.82%
Apple
SPY568.64-11.37
-1.96%
SPDR® S&P 500® ETF Trust
BTC.X70215.190000-2124.351600
-2.94%
Bitcoin cryptocurrency
TSLA249.85-7.70
-2.99%
Tesla
GME22.18-1.10
-4.73%
GameStop Corp

EVGN and

Correlation & Price change

A.I.dvisor tells us that EVGN and AXON have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EVGN and AXON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVGN
1D Price
Change %
EVGN100%
-5.00%
AXON - EVGN
30%
Poorly correlated
-3.53%
FATE - EVGN
29%
Poorly correlated
-4.82%
ARRY - EVGN
28%
Poorly correlated
+4.82%
BIOR - EVGN
27%
Poorly correlated
-1.15%
RARE - EVGN
27%
Poorly correlated
-1.72%
More